Additionally, we chose miRNA-29a-3p and miRNA-210-3p with a fold change ≤ 2, failed in our screening experiment, due to their probable significance in diseases associated with fibrosis found in databases (Table 1 ).
← all excerpts
Circulating miRNA-181b-5p, miRNA-223-3p, miRNA-210-3p, let 7i-5p, miRNA-21-5p and miRNA-29a-3p in patients with localized scleroderma as potential biomarkers.
1
—
—